Carrie Jones

Phase I clinical trial of drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read More

Vanderbilt University has announced this year’s Master Innovators including Carrie Jones, Colleen Niswender, and Alex Waterson. The recognition, presented by the Center for Technology Transfer and Commercialization, honors faculty whose groundbreaking research has been translated into transformative innovations, advancing their fields and making a significant impact on society. Read More

This year’s Excellence in Undergraduate Research Mentoring Award was awarded to Carrie Jones, associate professor of pharmacology, for her work understanding schizophrenia, Alzheimer’s disease and addiction and her willingness to support students in her lab. Read More